BSX
Price
$54.83
Change
-$0.05 (-0.09%)
Updated
Dec 6, 6:59 PM EST
55 days until earnings call
ZBH
Price
$115.85
Change
-$0.30 (-0.26%)
Updated
Dec 7, 9:38 AM EST
60 days until earnings call
Ad is loading...

Compare predictions BSX vs ZBH

Header iconBSX vs ZBH Comparison
Open Charts BSX vs ZBHBanner chart's image
Boston Scientific
Price$54.83
Change-$0.05 (-0.09%)
Volume$1.13M
CapitalizationN/A
Zimmer Biomet Holdings
Price$115.85
Change-$0.30 (-0.26%)
Volume$4.34K
CapitalizationN/A
View a ticker or compare two or three
BSX vs ZBH Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
BSX vs. ZBH commentary
Dec 07, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a Hold and ZBH is a Buy.

COMPARISON
Comparison
Dec 07, 2023
Stock price -- (BSX: $54.82 vs. ZBH: $116.13)
Brand notoriety: BSX: Notable vs. ZBH: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BSX: 57% vs. ZBH: 76%
Market capitalization -- BSX: $81.58B vs. ZBH: $23.79B
BSX [@Medical Specialties] is valued at $81.58B. ZBH’s [@Medical Specialties] market capitalization is $23.79B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $6.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 2 FA rating(s) are green whileZBH’s FA Score has 1 green FA rating(s).

  • BSX’s FA Score: 2 green, 3 red.
  • ZBH’s FA Score: 1 green, 4 red.
According to our system of comparison, BSX is a better buy in the long-term than ZBH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 4 TA indicator(s) are bullish while ZBH’s TA Score has 5 bullish TA indicator(s).

  • BSX’s TA Score: 4 bullish, 6 bearish.
  • ZBH’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ZBH is a better buy in the short-term than BSX.

Price Growth

BSX (@Medical Specialties) experienced а -1.12% price change this week, while ZBH (@Medical Specialties) price change was +1.94% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.87%. For the same industry, the average monthly price growth was +10.90%, and the average quarterly price growth was -9.09%.

Reported Earning Dates

BSX is expected to report earnings on Jan 31, 2024.

ZBH is expected to report earnings on Feb 05, 2024.

Industries' Descriptions

@Medical Specialties (+2.87% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for BSX with price predictions.
OPEN
A.I.dvisor published
a Summary for ZBH with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BSX($81.6B) has a higher market cap than ZBH($23.8B). BSX has higher P/E ratio than ZBH: BSX (67.11) vs ZBH (50.00). BSX YTD gains are higher at: 18.478 vs. ZBH (-8.394). BSX has higher annual earnings (EBITDA): 3.32B vs. ZBH (1.84B). BSX has more cash in the bank: 952M vs. ZBH (292M). ZBH has less debt than BSX: ZBH (5.68B) vs BSX (9.3B). BSX has higher revenues than ZBH: BSX (13.8B) vs ZBH (7.28B).
BSXZBHBSX / ZBH
Capitalization81.6B23.8B343%
EBITDA3.32B1.84B180%
Gain YTD18.478-8.394-220%
P/E Ratio67.1150.00134%
Revenue13.8B7.28B190%
Total Cash952M292M326%
Total Debt9.3B5.68B164%
FUNDAMENTALS RATINGS
BSX vs ZBH: Fundamental Ratings
BSX
ZBH
OUTLOOK RATING
1..100
2327
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
18
Undervalued
PROFIT vs RISK RATING
1..100
2881
SMR RATING
1..100
8185
PRICE GROWTH RATING
1..100
3356
P/E GROWTH RATING
1..100
8684
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZBH's Valuation (18) in the Medical Specialties industry is somewhat better than the same rating for BSX (83). This means that ZBH’s stock grew somewhat faster than BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (28) in the Medical Specialties industry is somewhat better than the same rating for ZBH (81). This means that BSX’s stock grew somewhat faster than ZBH’s over the last 12 months.

BSX's SMR Rating (81) in the Medical Specialties industry is in the same range as ZBH (85). This means that BSX’s stock grew similarly to ZBH’s over the last 12 months.

BSX's Price Growth Rating (33) in the Medical Specialties industry is in the same range as ZBH (56). This means that BSX’s stock grew similarly to ZBH’s over the last 12 months.

ZBH's P/E Growth Rating (84) in the Medical Specialties industry is in the same range as BSX (86). This means that ZBH’s stock grew similarly to BSX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXZBH
RSI
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
66%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
66%
Momentum
ODDS (%)
Bearish Trend 2 days ago
55%
Bullish Trend 3 days ago
52%
MACD
ODDS (%)
Bearish Trend 2 days ago
65%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
51%
Bullish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 7 days ago
58%
Bullish Trend 7 days ago
63%
Declines
ODDS (%)
Bearish Trend 29 days ago
53%
Bearish Trend 3 days ago
54%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
57%
Bearish Trend 3 days ago
49%
Aroon
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVH28.311.64
+6.15%
Evolent Health
CRMD3.610.07
+1.98%
CorMedix
LBAI13.08-0.06
-0.46%
Lakeland Bancorp
FRSX1.90-0.02
-1.04%
Foresight Autonomous Holdings Ltd
CQP58.03-2.82
-4.63%
Cheniere Energy Partners LP

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been closely correlated with SYK. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
-0.11%
SYK - BSX
66%
Closely correlated
-0.91%
ZBH - BSX
58%
Loosely correlated
+0.27%
ISRG - BSX
55%
Loosely correlated
+0.24%
RVTY - BSX
52%
Loosely correlated
+1.44%
ABT - BSX
52%
Loosely correlated
+0.57%
More

ZBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZBH has been loosely correlated with SYK. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ZBH jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZBH
1D Price
Change %
ZBH100%
+0.27%
SYK - ZBH
62%
Loosely correlated
-0.91%
TFX - ZBH
59%
Loosely correlated
+0.83%
BSX - ZBH
58%
Loosely correlated
-0.11%
SNN - ZBH
56%
Loosely correlated
+0.51%
ABT - ZBH
55%
Loosely correlated
+0.57%
More